News

A multicenter, double-blind, placebo-controlled study followed outpatients with major depression through acute, continuation and two phases of maintenance therapy (12 months each) with venlafaxine extended release compared to

Confirming the results of an earlier study, AstraZeneca's Seroquel (quetiapine fumarate) has demonstrated significant improvement in measures of depressive symptoms in a large-scale study examining the drug as

The library, developed by Dr Leroy Townsend, consists of lead candidates specifically designed toward key antiviral and oncology targets. Chimerix will incorporate promising candidates from the antiviral library

A preclinical evaluation study investigated the tolerability and anticancer activity of the mycobacterial cell wall-DNA complex (MCC) suspension, trademarked Urocidin, after intraperitoneal administration using a rat peritoneal DHD/K12/PROb

The randomization of 820 patients with osteoarthritis (OA) of the knee at 120 clinical sites in the US was initiated in late December 2005 and has now been

Bavituximab (formerly Tarvacin) is a monoclonal antibody with unique anti-viral and anticancer properties that has already demonstrated good tolerability in a phase I trial in patients with hepatitis

Under the terms of the agreement, Roche will provide R&D funding and milestone payments, and Entelos will conduct biosimulation research using its Metabolism PhysioLab platform, which utilizes a

Enablex (darifenacin) and Ditropan XL (oxybutynin extended-release) are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Both therapies are antimuscarinic

The results, which were presented at Digestive Disease Week, show that, after up to 96 weeks of treatment, 94% of nucleoside-naive HBeAg-negative chronic hepatitis B patients treated with